Standard
Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C) : a randomised, double-blind, placebo-controlled trial. / Johansen, Nicklas J.; Dejgaard, Thomas F.; Lund, Asger; Schluntz, Camilla; Frandsen, Christian S.; Forman, Julie L.; Albrechtsen, Nicolai J. Wewer; Holst, Jens J.; Pedersen-Bjergaard, Ulrik; Madsbad, Sten; Vilsbøll, Tina; Andersen, Henrik U.; Knop, Filip K.
I:
The Lancet Diabetes & Endocrinology, Bind 8, Nr. 4, 2020, s. 313-324.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Johansen, NJ, Dejgaard, TF, Lund, A, Schluntz, C, Frandsen, CS
, Forman, JL, Albrechtsen, NJW, Holst, JJ, Pedersen-Bjergaard, U, Madsbad, S, Vilsbøll, T, Andersen, HU
& Knop, FK 2020, '
Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial',
The Lancet Diabetes & Endocrinology, bind 8, nr. 4, s. 313-324.
https://doi.org/10.1016/S2213-8587(20)30030-9APA
Johansen, N. J., Dejgaard, T. F., Lund, A., Schluntz, C., Frandsen, C. S.
, Forman, J. L., Albrechtsen, N. J. W., Holst, J. J., Pedersen-Bjergaard, U., Madsbad, S., Vilsbøll, T., Andersen, H. U.
, & Knop, F. K. (2020).
Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial.
The Lancet Diabetes & Endocrinology,
8(4), 313-324.
https://doi.org/10.1016/S2213-8587(20)30030-9Vancouver
Johansen NJ, Dejgaard TF, Lund A, Schluntz C, Frandsen CS
, Forman JL o.a.
Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial.
The Lancet Diabetes & Endocrinology. 2020;8(4):313-324.
https://doi.org/10.1016/S2213-8587(20)30030-9Author
Johansen, Nicklas J. ; Dejgaard, Thomas F. ; Lund, Asger ; Schluntz, Camilla ; Frandsen, Christian S. ; Forman, Julie L. ; Albrechtsen, Nicolai J. Wewer ; Holst, Jens J. ; Pedersen-Bjergaard, Ulrik ; Madsbad, Sten ; Vilsbøll, Tina ; Andersen, Henrik U. ; Knop, Filip K. / Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C) : a randomised, double-blind, placebo-controlled trial. I: The Lancet Diabetes & Endocrinology. 2020 ; Bind 8, Nr. 4. s. 313-324.
Bibtex
@article{ac533e4fcae94f4c9edbe53aef06af03,
title = "Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial",
author = "Johansen, {Nicklas J.} and Dejgaard, {Thomas F.} and Asger Lund and Camilla Schluntz and Frandsen, {Christian S.} and Forman, {Julie L.} and Albrechtsen, {Nicolai J. Wewer} and Holst, {Jens J.} and Ulrik Pedersen-Bjergaard and Sten Madsbad and Tina Vilsb{\o}ll and Andersen, {Henrik U.} and Knop, {Filip K.}",
year = "2020",
doi = "10.1016/S2213-8587(20)30030-9",
language = "English",
volume = "8",
pages = "313--324",
journal = "The Lancet Diabetes & Endocrinology",
issn = "2213-8587",
publisher = "The Lancet Publishing Group",
number = "4",
}
RIS
TY - JOUR
T1 - Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C)
T2 - a randomised, double-blind, placebo-controlled trial
AU - Johansen, Nicklas J.
AU - Dejgaard, Thomas F.
AU - Lund, Asger
AU - Schluntz, Camilla
AU - Frandsen, Christian S.
AU - Forman, Julie L.
AU - Albrechtsen, Nicolai J. Wewer
AU - Holst, Jens J.
AU - Pedersen-Bjergaard, Ulrik
AU - Madsbad, Sten
AU - Vilsbøll, Tina
AU - Andersen, Henrik U.
AU - Knop, Filip K.
PY - 2020
Y1 - 2020
U2 - 10.1016/S2213-8587(20)30030-9
DO - 10.1016/S2213-8587(20)30030-9
M3 - Journal article
VL - 8
SP - 313
EP - 324
JO - The Lancet Diabetes & Endocrinology
JF - The Lancet Diabetes & Endocrinology
SN - 2213-8587
IS - 4
ER -
